The news reports the resolution to dissolve BB Laboratories (BBL), the subsidiary. All business to be terminated by March 31, 2026, liquidation not yet decided, and financial impact expected to be minor in the fiscal year ending June 2027.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"2385","jir_company_name":"Total Medical Research Holdings Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-08-12","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/2385-20260812-03.pdf","jir_short_summary":"The news reports the resolution to dissolve BB Laboratories (BBL), the subsidiary. All business to be terminated by March 31, 2026, liquidation not yet decided, and financial impact expected to be minor in the fiscal year ending June 2027.","jir_summary":"### Overview of the business reorganization\nThis notice reports the dissolution resolution of BBL as part of the structural reform of the group, which centers on the healthcare business, including withdrawal from BBL, termination of all businesses, and transfer of the cosmetics business to NYI. The transfer to NYI was completed on March 1, 2026, all businesses were terminated on March 31, and dissolution was reached.\n\n### Outlook and impact\nLiquidation associated with the dissolution is not yet determined, and the impact on the 2027 fiscal year is expected to be minor. The key indicators show trends for the most recent three fiscal years, but the impact from the business termination is described as limited.","jir_financial_highlights":"Revenue: 904,226 \u5343\u5186 (YoY not disclosed)\nNet income for the period: 9,140 \u5343\u5186 (YoY not disclosed)","jir_category":"","jir_hashtags":"#\u7dcf\u533b\u7814\u30db\u30fc\u30eb\u30c7\u30a3\u30f3\u30b0\u30b9, #SubsidiaryDissolution, #BusinessPortfolioReview","jir_key_figures":"BBL dissolution date: 2026-08-12\nTransfer completion to NYI: 2026-03-01\nBusiness termination date: 2026-03-31","jir_meta_title":"\u3010Total Medical Research Holdings\u3011Notice of Subsidiary Dissolution\uff5cAugust 12, 2026","jir_meta_description":"Total Medical Research Holdings has resolved to dissolve its subsidiary BB Laboratories (BBL). After transferring the placenta cosmetics business to NYI, all businesses will be terminated. Minor impact expected for the 2027 fiscal year.","jir_og_title":"Total Medical Research Holdings \uff5c Notice of Subsidiary Dissolution","jir_og_description":"Resolution to dissolve subsidiary BBL. No termination date for business or liquidation yet; expected minor impact going forward.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":59673,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"executive_change","footnotes":""},"sector":[],"importance":[],"class_list":["post-102405","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n